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After the outbreak of COVID-19 unprecedented changes in the healthcare systems world-
wide were necessary resulting in a reduction of urological capacities with postponements of
consultations and surgeries.
Material and methods
An email was sent to 66 urological hospitals with focus on robotic surgery (RS) including a
link to a questionnaire (e.g. bed/staff capacity, surgical caseload, protection measures
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during RS) that covered three time points: a representative baseline week prior to COVID-
19, the week of March 16th-22nd and April 20th-26th 2020. The results were evaluated using
descriptive analyses.
Results
27 out of 66 questionnaires were analyzed (response rate: 41%). We found a decrease of
11% in hospital beds and 25% in OR capacity with equal reductions for endourological,
open and robotic procedures. Primary surgical treatment of urolithiasis and benign prostate
syndrome (BPS) but also of testicular and penile cancer dropped by at least 50% while the
decrease of surgeries for prostate, renal and urothelial cancer (TUR-B and cystectomies)
ranged from 15 to 37%. The use of personal protection equipment (PPE), screening of staff
and patients and protection during RS was unevenly distributed in the different centers–
however, the number of COVID-19 patients and urologists did not reach double digits.
Conclusion
The German urological landscape has changed since the outbreak of COVID-19 with a sig-
nificant shift of high priority surgeries but also continuation of elective surgical treatments.
While screening and staff protection is employed heterogeneously, the number of infected
German urologists stays low.
Introduction
On March 11th 2020 the WHO declared the coronavirus disease 2019 (COVID-19) caused by
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) a pandemic. At that time,
1,567 cases were confirmed in Germany with three deaths due to COVID-19 after the first
German patient was identified on January 27th 2020 [1]. Germany is a federal state, and han-
dling of the lockdown stayed in the responsibility of the individual states. Therefore, different
steps were taken at different time points: the first states declared the lockdown in the week of
March 16th 2020. Measures included social distancing to “flatten the curve” based on simula-
tion scenarios as well as drastic changes in the health care system [2]. In an efficient manner,
triage systems and recommendations were developed by several international societies/associ-
ations to meet these challenges also in urology [3–5].
Based on those recommendations, both the healthcare system and the individual hospital
had to respect different groups: infected patients, diagnosed and future urological patients as
well as healthcare workers.
This study aims to give an insight to the urological situation and changes in surgical capaci-
ties, therapeutic and deferral strategies and management of staff and patients since the
COVID-19 outbreak in Germany.
Material and methods
Online survey
On May 8th 2020, 66 urological departments in Germany with a focus on laparoscopic/robotic
surgery were contacted following an initiative of the German Association of Urology working
group “Laparoscopy and robot-assisted surgery”. An email was send to the heads of the
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urological departments which included a link to an online questionnaire using the Google
Docs open-source survey tool [6]. The survey was conducted in accordance with the Checklist
of Reporting Results of internet-E-Surveys (CHERRIES) [7]. For successful completion of the
survey, answering of all questions was not mandatory. A meticulous completion of the ques-
tionnaire was estimated to take 90 to 120 minutes. All members of our working group piloted
the survey and no technical problems occurred. A similar survey was conducted by an Italian
COVID-19 group and published by Rocco et al. [8].
The complete survey (S1 File) included detailed queries on numbers of available hospital
beds and operating room (OR) capacity, staff members, surgical caseloads with subcategoriza-
tion of surgeries at three different time points: week 1) baseline week that portrays the num-
bers of a regular/representative week before the outbreak of COVID-19, week 2) March 16th to
22nd 2020 which represent the first week after the lockdown in Germany (confirmed cases in
Germany on March 16th 2020: 6,012 with 13 deaths) and week 3) April 20th to 26th (confirmed
cases in Germany on April 20th 2020: 141,672; 4,404 deaths and approximately 91,500 recov-
ered) [1]. For weeks 2 and 3, participants were asked about the rates of infected urologists and
patients as well as protective measures during daily routine and robotic surgery (RS).
Preliminary results were presented during a webinar focusing on the development of RS
after the outbreak of COVID-19 organized by the DGRU on May 14th 2020, and participants
were reminded to complete the questionnaire before the data collection was closed on May
24th 2020.
Daily situation report—Robert Koch Institute
The daily situation report of the pandemic in Germany and constantly updated case numbers
of infected/recovered patients and death rates, including analysis of the 16 German federal
states can be found on the homepage of the German Government´s agency for disease control
and prevention, “Robert Koch Institute” (RKI) [1].
Statistical analyses
SPSS 25 was used for statistical analysis. Categorial data are shown as frequencies and propor-
tions; continuous variables are given as median and range. For improved visualization in the
graphs, continuous data (e.g. number of staff members, cases) were summed to a total number
with subsequent division to percentages. Chi-square and fisher’s exact test were used to iden-
tify differences in the the varying practice settings with a statistical significance p<0.05.
Results
27 completed questionnaires were analyzed (41%) and included 14 responses from teaching
hospitals, eight university hospitals and five non-academic centers. Each center (19 public and
eight private) documented shifts in their numbers and capacities after the beginning of the
pandemic compared to the representative baseline week before the outbreak.
Developments in hospital capacities
While only a moderate cut-down of available beds within the different urological departments
was found (median beds at baseline: 49 vs. 45 in March and 43 in April), the OR capacity was
reduced distinctly by more than 25%, however this was handled heterogeneously and varied
from a decrease to 22% of the initial capacity to no reduction. In total, 4571 surgeries were doc-
umented in the three requested weeks with 1195 emergency cases and 3376 scheduled cases.
The number of scheduled patients per center declined from a median of 58 scheduled surgeries
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in the baseline week compared to 31 and 29 cases in March and April. In the same period, an
increase of emergency cases could be observed with 363 in a regular week vs. 448 after the
COVID-19 outbreak in March and 384 emergency surgeries in April (Fig 1).
No significant differences in management of OR capacities could be observed between uni-
versity, teaching and non-academic hospitals in March (p = 0.53) and April (p = 0.29).
The majority of scheduled cases in the baseline week represented oncological surgeries
(44% of total scheduled cases) followed by urolithiasis (24%), surgical therapy of BPS (15%)
and other surgeries (e.g. reconstructive, transgender, pediatric) with 18%. In the following
weeks, declines could be observed in each of these subgroups (Fig 2).
Compared to the average numbers in the preceding weeks with a total of 366 cases, stone
therapy (47% kidney and 53% ureteral stones) declined by 50%. Oncological surgeries were
subclassified according to their priority and less urgent cancer therapies for low risk prostate
cancer (baseline week: a total of 43 cases compared to 24 in March and 17 in April) and small
renal masses (SRM) (reduction to 49% in March and April) were postponed, resulting in an
increased or stable portion of surgeries for more advanced tumor constellations; the total
number of prostatectomies for advanced prostate cancer rose from a total of 22 in the baseline
week to 28 cases in April. Urothelial cancer treatment dropped from 297 cases to 211 in March
and 195 in April with a comparable decrease for TUR-B and radical cystectomies. Remarkably,
the rates of rare tumor entities including upper tract urothelial cancer as well as penile and
testicular cancer decreased by 48–85% in comparison to the pre-COVID-19 case numbers
(Fig 3).
Robotic surgery in times of COVID-19
In the pre-COVID-19 era, a median capacity of 4 robotic operating rooms/week was reported
by the respondents ranging from two up to 20 robotic days/week with a maximum of 45
robotic cases in one high-volume center. Comparable to the developments for endourological
Fig 1. Changes in capacities. Trends in 27 urological departments (percentage change of total numbers (left y-axis,
orange bars) and median number/center (right y-axis, blue line) for available beds (a), staff members (b) summed up
operating rooms/week (c). D shows the portion of reductions in OR capacities in the different centers (y-axis).
https://doi.org/10.1371/journal.pone.0239027.g001
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(25%) and open/laparoscopic OR capacities (27%), robotic OR capacity decreased by 26% to a
median of three days/week and a maximum of 12 robotic OR days/week in March but slowly
increased to 83% of the initial capacity in April. Three centers suspended their urological
robotic program in the weeks of March or April¸ one department paused RS completely since
Fig 2. Changes in scheduled cases. Percentage change of total numbers (left y-axis, orange bars) and median number/
center (right y-axis, blue line) for scheduled cases subdivided into oncological procedures (a), stone therapy (b),
surgical treatment of benign prostate syndrome (c) and other surgeries (d).
https://doi.org/10.1371/journal.pone.0239027.g002
Fig 3. Changes in oncological surgeries. Percentage change of surgical therapy of prostate cancer after stratification
according to the D’Amico score (a), renal masses with clinical stages (b), subgroups of procedures for urothelial cancer
(c) and penile and testicular cancer (d).
https://doi.org/10.1371/journal.pone.0239027.g003
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the outbreak. There was no difference in the general use of intraoperative safety precautions
between public and private hospitals (42 vs. 50%, p = 1.00). Fig 4 summarizes the protective
measures that were taken for RS.
Patient’s screening
COVID-19 screening at the time of admission of patients comprised questionnaires in 78% of
the institutions and physical examination for fever in 44%. In 52%, patients undergoing sur-
gery were tested for COVID-19 prior to the operation with a comparable percentage in public
and private hospitals (p = 0.21). A chest CT for screening was routinely employed in only one
hospital. In seven departments patients were identified as COVID-19 positive either after
screening (n = 3) or presentation of symptoms (n = 4).
Staff management and safety precautions
To minimize the risk of virus transmission to the hospital staff, wearing of masks was required
in all hospitals. This included regular surgical masks but also hand-sewn masks (19%). Regular
screening of the staff with testing for COVID-19 was reported by 7% of the respondents and in
only two urological departments the staff members’ temperature/fever was checked daily. To
reduce the exposition to potentially infected patients, home office or (un)paid leave was
enabled in 59% resulting in a reduction of the median staff members per center from 17 in the
baseline week to 16 in March and April. Eight out of a total of 505 urologists (1.6%) were tested
positive for SARS-CoV-2 infection.
Discussion
When COVID-19 hit Europe, the impressive rates of infected patients and deaths in Italy as
the first affected European country indicated that immediate and extraordinary steps were
needed to face this threat. This resulted in unprecedented changes in the healthcare systems
across the world. In hospitals, surgical capacity decreased significantly to reserve ventilators
and ICU beds for COVID-19 patients. A global survey by Teoh et al. summarized a drop of
81–100% of outpatient clinic appointments and 48% of urological surgeries after the beginning
Fig 4. Protection during robotic surgery. Implementation of protection measures (in %) during robot-assisted
surgeries in the different participating German centers.
https://doi.org/10.1371/journal.pone.0239027.g004
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of the pandemic [9]. To manage these reductions, new triage systems were implemented to
identify those at high risk of COVID-19 and those at risk from being affected by delayed treat-
ment of their urological disease. In April 2020 the European Association of Urology published
recommendations in a remarkable short time frame based on the available information [3].
Surgeries should be scheduled only after risk stratification into one of four categories: low,
intermediate, high priority and emergency. However, elective surgeries within the lowest risk
category (including treatment of urolithiasis and BPS) were reported in March and in April.
On the other hand, a 25% decrease of intermediate and high priority surgeries was also
observed. This might be contributed to the differing policies of healthcare systems in the Ger-
man federal states as well as hospital policies which may also explain the heterogeneous han-
dling of OR capacities: while some respondents reported a reduction of more than 50%, others
continued with a mostly unchanged program. Unsurprisingly, these findings for Germany are
in line with a global survey that also revealed an inconsistent implementation of urological
COVID-19 guidelines on procedure prioritization across the different practice settings and
regions worldwide [10].
Major concern of the elective treatment of patients potentially harboring COVID-19 with-
out clinical symptoms or initial negative testing have been raised after Lei et al. published
results of 34 patients undergoing surgery while unknowingly being infected in January 2020 in
Wuhan [11, 12]. All of these patients developed COVID-19 pneumonia with need for ICU
care in 44% and a death rate of 21%. This disadvantageous postoperative course for COVID-
19 positive patients was also supported by Nepogodiev [13]. The Diagnosis Related Group sys-
tem in Germany determines a minimum hospital stay depending on the type of procedure.
Major urological surgeries require a postoperative stay of at least 4–10 days, a time span that
largely covers the incubation period of COVID-19 [14]. In a German study of 337 patients
after radical prostatectomy (February to April 2020), no clinically evident COVID-19 infection
occurred in the early postoperative time [15]. Accordingly, only a minority of the respondents
reported COVID-19 positive patients in their departments in March and April.
The deferral of procedures and the fear of virus transmission in a urological department
(outpatient or hospital) in combination with social distancing resulted in a further worrisome
phenomenon: Novara et al. described a 55% decrease of urological consultations in emergency
departments after the outbreak of the pandemic in Italy [16]. In contrast, our study confirmed
an increase in urological emergency cases, like ureteral stent-placement, but we noticed a dis-
tinct reduction of TUR-Bs and primary surgical treatment of testicular cancer. Especially for
the latter, this was surprising, as the reduced OR capacity was a rather negligible aspect; an
orchiectomy is a short operation which can be done in a same-day surgery setting [17]. More
likely, patients postponed an urological consultation for macrohematuria or a testicular nodule
due to fear of a SARS-CoV-2 infection [18]. This is corroborated by further studies showing
that the number of cardiac catherization for ST-elevation myocardial infarction decreased by
40 and 38% during the first weeks of COVID-19 [19, 20]. This observation in the context of a
drop in prostate biopsy rates across Europe to 38% may indicate that a new wave of patients
with possibly even more advanced disease might occur in the next months when outpatient
care normalizes [21].
40% of the European participants of a global survey reported about voluntary or mandatory
deployment to COVID-19 patient care and/or staff shortage [9]. Hence, in addition to contin-
ued high-quality patient care, protection of the healthcare workers is of utmost importance
and the risk of virus transmission due to (unknown) contact with infected patients should be
minimized. Our study shows a wide range of screening measures that was not always in line
with the EAU recommendations: while some hospitals implemented triage admission wards
with routine swabs on every patient, others relied solely on questionnaires.
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Porter et al. suggested in a recent review that every patient should be managed as COVID-
19 positive and one of the first recommendations in personal protection equipment (PPE) in
the daily routine in and outside of the hospital is the use of a mask [22]. According to a Ger-
man survey by Paffenholz et al. only a minority of respondents experienced a regular or con-
tinuous shortage of masks or gowns with no significant differences between university and
regional hospitals [23]. In each of the 27 participating centers of the present study masks were
included in the regular PPE. To adapt to a potential shortage of masks especially in the early
days of the pandemic, some hospitals also used hand-sewn masks for patient care outside of
the operating room.
Surgical teams are exposed to a high risk of contagion [24]. Especially in the initial phase
with intubation and the preceding manual ventilation a high risk of contagion was described
during the SARS (“bird flu”) outbreak in 2002 [25]. In the later period, surgical plume may
endanger the operating staff as the generated aerosols may theoretically contain viable particles
as shown for several viruses [26–28]. Hence, several surgical societies recommended a
restrained use of laparoscopic or robotic procedures due to a possibly higher risk of aerosol
generation [29, 30]. In our study we found an overall reduction in OR capacity by one fourth,
but we did not observe a higher cut-back in robotic OR capacity compared to endourology/
open procedures. Notably, less than 50% of the respondents reported taking special safety mea-
sures during robotic surgery, and only a minority routinely used FFP2/3 mask or a closed fil-
tration system to protect the staff. This rather restricted intraoperative use of PPE can also be
observed in other surgical specialties: routine PPE was reported by only 9.1% of the respon-
dents of a global survey conducted by the International Society of University Colon and Rectal
Surgeons [31] and solely 35% of minimally invasive emergency general surgeries in Italy were
performed using measures for reduced aerosol dispersion [32]. However, with a rate of 1.6%
SARS-CoV-2 positive (tested) urologists in our study this rather deviant inconsistent imple-
mentation of the “EAU Robotic Urology Section (ERUS) guidelines during COVID-19 emer-
gency” [5] did not translate into a higher infection rate.
Several limitations have to be discussed. The response rate was below 50% possibly leading
to a selection bias and the distribution of the online questionnaire focused on departments
(sub)specialized on RS. Therefore, these findings cannot be generalized for institutions focus-
ing on urolithiasis or reconstructive surgery as well as outpatient care. Furthermore, our
results also reflect the differences in the German federal healthcare system and further analyses
should elucidate the potential influence of varying states and hospital policies. Yet, in the pres-
ent preliminary analysis, we observed no significant differences between varying practice set-
tings (university, teaching and non-academic hospitals and private vs. public), a fact that was
also confirmed globally [10].
The survey included detailed questions on capacities and case numbers but intentionally
precluded further information on patient outcomes for ethical reasons. This initial study
wanted to describe the situation in Germany during the first weeks of the pandemic and fur-
ther studies are needed to elucidate the individual patient results before, during and hopefully
after the COVID-19 era. However, in case of a continued pandemic, the evaluation of the
changes in practice patterns and patient management during the first wave of COVID-19 and
the subsequent impact on SARS-CoV-2 infection and death rates might be a foundation for
future particularized and evidence-based guidelines to protect our patients and staff.
Conclusion
The outbreak of COVID-19 has changed healthcare systems worldwide including the daily
routine in urological departments. While several urological societies recommended
PLOS ONE Changes in urology in Germany since the COVID-19 outbreak
PLOS ONE | https://doi.org/10.1371/journal.pone.0239027 September 15, 2020 8 / 11
postponement of elective therapies, we found a heterogeneous implementation in Germany
with continuation of low priority cases as well as deferrals or shifts even of urgent surgeries.
Screening strategies and staff protection is varying widely between the responding institutions,
however, the numbers of infected German urologists and patients stayed low in our survey.
Supporting information
S1 File. Online questionnaire. The complete Google Doc survey included questions on capac-
ities and surgical caseloads with subcategorization of surgeries at three different time points
and protective measures and staff/patient management after the COVID-19 outbreak.
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